Tivicay (dolutegravir)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
June 2016
USE IN SPECIFIC POPULATIONS
Pediatric Patients
The safety, virologic, and immunologic responses in subjects who...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts